Treatment of 18 children with scabies or cutaneous larva migrans using ivermectin

M del Mar Sáez-De-Ocariz1, C Durán McKinster, L Orozco-Covarrubias

  • 1Department of Dermatology, National Institute of Pediatrics, Insurgentes Sur 3700 C, Mexico City 04530, Mexico.

Insights

Ivermectin effectively treats scabies and cutaneous larva migrans in children, even those with complex conditions. This study found it safe and well-tolerated, offering a valuable alternative for pediatric parasitic skin infections.

Area of Science:

  • Dermatology
  • Parasitology
  • Pediatrics

Background:

  • Ivermectin is used for filarial diseases, scabies, and larva migrans.
  • Safety concerns exist for ivermectin use in children under 5 or weighing less than 15 kg.

Purpose of the Study:

  • To evaluate the safety and efficacy of ivermectin for treating scabies and cutaneous larva migrans in children.
  • To assess ivermectin's effectiveness in pediatric patients with complex medical histories.

Main Methods:

  • Retrospective case series of 18 children (14 months to 17 years) treated with ivermectin.
  • Included patients with crusted scabies, common scabies, and cutaneous larva migrans.
  • Dosage and adverse effects were monitored.

Main Results:

  • Successful treatment in all 18 pediatric patients.
  • 15 patients cured with a single dose; 3 with crusted scabies required a second dose.
  • No significant adverse effects were reported.

Conclusions:

  • Ivermectin is a safe and effective treatment for pediatric cutaneous parasitosis.
  • It provides a valuable alternative for treating scabies and cutaneous larva migrans in children.
  • Further research may support broader use in pediatric populations.

Related Concept Videos

Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...